These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 25855730

  • 1. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.
    Gromowski GD, Firestone CY, Whitehead SS.
    J Virol; 2015 Jun; 89(12):6328-37. PubMed ID: 25855730
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of the live-attenuated Japanese encephalitis vaccine SA14-14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo.
    Yun SI, Song BH, Polejaeva IA, Davies CJ, White KL, Lee YM.
    J Gen Virol; 2016 Oct; 97(10):2575-2591. PubMed ID: 27498826
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain.
    Yang J, Yang H, Li Z, Wang W, Lin H, Liu L, Ni Q, Liu X, Zeng X, Wu Y, Li Y.
    Viruses; 2017 Jan 21; 9(1):. PubMed ID: 28117725
    [Abstract] [Full Text] [Related]

  • 8. The A66G back mutation in NS2A of JEV SA14-14-2 strain contributes to production of NS1' protein and the secreted NS1' can be used for diagnostic biomarker for virulent virus infection.
    Wang J, Li X, Gu J, Fan Y, Zhao P, Cao R, Chen P.
    Infect Genet Evol; 2015 Dec 21; 36():116-125. PubMed ID: 26384477
    [Abstract] [Full Text] [Related]

  • 9. Genetic and neuroattenuation phenotypic characteristics and their stabilities of SA14-14-2 vaccine seed virus.
    Liu X, Zhao D, Jia L, Xu H, Na R, Ge Y, Liu S, Yu Y, Li Y.
    Vaccine; 2018 Jul 25; 36(31):4650-4656. PubMed ID: 29954631
    [Abstract] [Full Text] [Related]

  • 10. [Construction of infectious Japanese encephalitis virus clone based on the cDNA template of the attenuated live vaccine production strain SA14-14-2].
    Zeng M, Jia LL, Yu YX, Dong GM, Liu WX, Wang ZW, Li DF.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar 25; 19(1):9-11. PubMed ID: 16201461
    [Abstract] [Full Text] [Related]

  • 11. A novel amino acid site closely associated with the neurovirulence of live, attenuated Japanese encephalitis vaccine (SA14-14-2 strain).
    Yang H, Fan F, Liu L, Liu J, Sun Y, Xie A, Shi X, Liu L, Yu Y, Li Y, Ge Y, Zeng X, Yang H.
    Vaccine; 2020 Mar 04; 38(11):2636-2642. PubMed ID: 32044162
    [Abstract] [Full Text] [Related]

  • 12. Genotype-specific neutralization determinants in envelope protein: implications for the improvement of Japanese encephalitis vaccine.
    Ye Q, Xu YP, Zhang Y, Li XF, Wang HJ, Liu ZY, Li SH, Liu L, Zhao H, Nian QG, Deng YQ, Qin ED, Qin CF.
    J Gen Virol; 2015 Aug 04; 96(8):2165-2175. PubMed ID: 25908779
    [Abstract] [Full Text] [Related]

  • 13. Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14.
    Ni H, Chang GJ, Xie H, Trent DW, Barrett AD.
    J Gen Virol; 1995 Feb 04; 76 ( Pt 2)():409-13. PubMed ID: 7844560
    [Abstract] [Full Text] [Related]

  • 14. Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity.
    Xu G, Xu X, Li Z, He Q, Wu B, Sun S, Chen H.
    Vaccine; 2004 May 07; 22(15-16):1846-53. PubMed ID: 15121294
    [Abstract] [Full Text] [Related]

  • 15. Construction and preliminary investigation of a novel dengue serotype 4 chimeric virus using Japanese encephalitis vaccine strain SA14-14-2 as the backbone.
    Li Z, Yang H, Yang J, Lin H, Wang W, Liu L, Zhao Y, Liu L, Zeng X, Yu Y, Li Y.
    Virus Res; 2014 Oct 13; 191():10-20. PubMed ID: 25091563
    [Abstract] [Full Text] [Related]

  • 16. Genetic and phenotypic properties of vero cell-adapted Japanese encephalitis virus SA14-14-2 vaccine strain variants and a recombinant clone, which demonstrates attenuation and immunogenicity in mice.
    Gromowski GD, Firestone CY, Bustos-Arriaga J, Whitehead SS.
    Am J Trop Med Hyg; 2015 Jan 13; 92(1):98-107. PubMed ID: 25311701
    [Abstract] [Full Text] [Related]

  • 17. A single nucleotide mutation in NS2A of Japanese encephalitis-live vaccine virus (SA14-14-2) ablates NS1' formation and contributes to attenuation.
    Ye Q, Li XF, Zhao H, Li SH, Deng YQ, Cao RY, Song KY, Wang HJ, Hua RH, Yu YX, Zhou X, Qin ED, Qin CF.
    J Gen Virol; 2012 Sep 13; 93(Pt 9):1959-1964. PubMed ID: 22739060
    [Abstract] [Full Text] [Related]

  • 18. The pre membrane and envelope protein is the crucial virulence determinant of Japanese encephalitis virus.
    Leng SL, Huang R, Feng YN, Peng LJ, Yang J, Li YH.
    Microb Pathog; 2020 Nov 13; 148():104492. PubMed ID: 32916243
    [Abstract] [Full Text] [Related]

  • 19. Biological and genetic properties of SA₁₄-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans.
    Song BH, Yun GN, Kim JK, Yun SI, Lee YM.
    J Microbiol; 2012 Aug 13; 50(4):698-706. PubMed ID: 22923123
    [Abstract] [Full Text] [Related]

  • 20. Envelope protein gene based molecular characterization of Japanese encephalitis virus clinical isolates from West Bengal, India: a comparative approach with respect to SA14-14-2 live attenuated vaccine strain.
    Sarkar A, Banik A, Pathak BK, Mukhopadhyay SK, Chatterjee S.
    BMC Infect Dis; 2013 Aug 08; 13():368. PubMed ID: 23927571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.